Literature DB >> 6368555

Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture.

H Sage, C Johnson, P Bornstein.   

Abstract

A unique and heretofore undescribed glycoprotein with unusual properties has been purified and characterized from the culture medium of endothelial cells. This protein is synthesized constitutively by bovine, porcine, and human endothelial cells, by vascular smooth muscle cells, and by fibroblasts from dermis and ligament. It is also a biosynthetic product of some murine malignant and/or transformed cell lines but was not uniformly observed in cells derived from human neoplasms. The glycoprotein exhibited an apparent molecular weight by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of approximately 39,000 before reduction, and of approximately 43,000 (43K protein) in the presence of dithiothreitol. Amino acid analysis revealed high levels of potentially acidic residues (Asx + Glx = 303 residues/1000) and of cysteine (35 residues/1000). Limited proteolysis indicated that both disulfide bonds and mannosylated sites were distributed throughout the protein chain. Neither phosphate nor sulfate was incorporated into the 43K protein during biosynthetic labeling of endothelial cells. In addition, the 43K protein did not bind to heparin, thrombin, gelatin, or fibronectin and displayed no affinity for [3H]diisopropyl fluorophosphate. In contrast, the 43K protein demonstrated a high affinity binding to bovine serum albumin which was dissociable only by sodium dodecyl sulfate. A complete lack of identity with several prominent serum and platelet proteins and with other mesenchymal cell products was shown by one- and two-dimensional peptide mapping, affinity chromatography, and immunological studies. Immunofluorescence staining of endothelial cells showed a granular distribution for the 43K protein that was typical of a secreted protein. The function of this apparently novel glycoprotein is presently not known. Its synthesis by normal mesenchymal cells and by malignant or transformed cells of both ectodermal and endodermal origin suggests a general role in cell function that is independent of transformation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368555

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Facilitated diffusion and membrane permeation of fatty acid in albumin solutions.

Authors:  E Barta; S Sideman; J B Bassingthwaighte
Journal:  Ann Biomed Eng       Date:  2000-03       Impact factor: 3.934

2.  Tumor microenvironment and nanotherapeutics.

Authors:  Meenakshi Upreti; Amar Jyoti; Pallavi Sethi
Journal:  Transl Cancer Res       Date:  2013-08-01       Impact factor: 1.241

3.  SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.

Authors:  S A Rempel; W A Golembieski; J L Fisher; M Maile; A Nakeff
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

4.  MB1, a quail leukocyte-endothelium antigen: partial characterization of the cell surface and secreted forms in cultured endothelial cells.

Authors:  M C Labastie; T J Poole; B M Péault; N M Le Douarin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 5.  Transmembrane transport of fatty acids in the heart.

Authors:  W Stremmel
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

Review 6.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

7.  SPARC/osteonectin mRNA is induced in blood vessels following injury to the adult rat cerebral cortex.

Authors:  D B Mendis; G O Ivy; I R Brown
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

8.  Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.

Authors:  Alexandre Chlenski; Lisa J Guerrero; Radhika Peddinti; Jared A Spitz; Payton T Leonhardt; Qiwei Yang; Yufeng Tian; Helen R Salwen; Susan L Cohn
Journal:  Mol Cancer       Date:  2010-06-04       Impact factor: 27.401

9.  Changes in osteonectin distribution and levels are associated with mineralization of the chicken tibial growth cartilage.

Authors:  M Pacifici; O Oshima; L W Fisher; M F Young; I M Shapiro; P S Leboy
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

10.  The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.

Authors:  P Bhoopathi; C Chetty; M Gujrati; D H Dinh; J S Rao; S S Lakka
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.